CTOs on the Move

Jounce Therapeutics

www.jouncetx.com

 
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients through a biomarker-driven approach. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within the human tumor microenvironment to prioritize targets, and then identifies related biomarkers designed to match the right immunotherapy to the right patient. Jounce is developing two clinical-stage programs as well as advancing and building out its broad and wholly-owned discovery pipeline of immuno-oncology targets, including those expressed ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.jouncetx.com
  • 1030 Massachusetts Avenue
    Cambridge, MA USA 02138
  • Phone: 857.259.3840

Executives

Name Title Contact Details
Nathan Doyle
Associate Director of Information Technology Profile

Funding

Jounce Therapeutics raised $34.9M on 10/29/2020
Jounce Therapeutics raised $56.2M on 03/10/2021

Similar Companies

Allergy Laboratories Inc

Allergy Laboratories Inc is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Danner Cytology Consultants

Danner Cytology Consultants is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ontario Assocation of Medical Laboratories

Ontario Assocation of Medical Laboratories is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PRACS Institute

PRACS Institute, Ltd. is a Fargo, ND-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medstar Laboratory

Medstar Laboratory, Inc. was funded in 1974 and serviced the Chicago metropolitan area. In February 2001, the Patel family took ownership. Under their administration the company has expanded its client base to Wisconsin and Indiana experiencing an extraordinary growth.